Information  X 
Enter a valid email address
  Print          More announcements

Monday 26 April, 2021

JP Morgan Sec LLC

AON PLC 8.3

RNS Number : 6282W
J.P. Morgan Securities LLC
26 April 2021
 

 Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

AON plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.01 ordinary shares

Date of dealing

 23 April 2021

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

6,258,421  2.77

2,147,067  0.95

(2) Derivatives (other than options)

1,890,707  0.84

39,418  0.02

(3)Optionsandagreementstopurchase/sell

45,000  0.02

355,600  0.16

Total

8,194,128  3.63

2,542,085  1.13

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

  Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (USD)

 

  (Note 5)

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

 

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

57

 80

 40

 18,320

 2

 2

 2

 1

 2

 6

 580

 25

 928

 100

 40

 14

 2

 2

 300

 300

 600

 2,000

 700

 300

 8

 

 57

 120

 66

 16,927

 400

 2

 4

 9

 200

 26

 4

 382

 11

 3

 3

 4

 25

 4

 4

 928

 307

 10

 59

 7

 2

 2,000

 52

 111

 3

 3

230.5900  USD

230.7985  USD

230.8800  USD

230.8900  USD

230.9100  USD

230.9200  USD

230.9450  USD

231.0600  USD

231.1100  USD

231.1467  USD

231.1902  USD

231.2112  USD

231.2713  USD

231.2800  USD

231.2850  USD

231.2893  USD

231.3300  USD

231.3350  USD

231.3767  USD

231.3867  USD

231.4108  USD

231.4168  USD

231.4357  USD

231.4733  USD

231.5300  USD

 

230.5900  USD

230.7985  USD

230.8000  USD

230.8900  USD

230.9050  USD

230.9200  USD

230.9500  USD

231.0300  USD

231.0550  USD

231.0785  USD

231.0925  USD

231.1211  USD

231.1327  USD

231.1600  USD

231.1800  USD

231.1900  USD

231.2112  USD

231.2300  USD

231.2500  USD

231.2713  USD

231.2788  USD

231.2900  USD

231.2922  USD

231.3086  USD

231.3350  USD

231.4168  USD

231.4640  USD

231.4766  USD

231.5800  USD

231.5900  USD

 

 

 

 

 

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(USD)

(Note 5)

Equity Swap

Decrease Long

 

 

Increase Short

 

25

 2,000

 

 928

 2

231.2112  USD

231.4168  USD

 

231.2713  USD

231.3350  USD

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price (USD)

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5) (USD)

Call Option

Purchased

18,800

240.00

American

15/10/2021

11.00

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.

 

  None

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    Yes

 

Dateofdisclosure

26 April 2021

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 

 

 

 

 

 

 

 

SUPPLEMENTAL   FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND  RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   8.1(a)   & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS  (Note   1)

 

 

 

Productname,

e.g. call option

Written, orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2) (USD)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Call Option

Call Option

Call Option

Put Option

Call Option

Call Option

Put Option

Call Option

Put Option

Written

Written

Written

Written

Written

Purchased

Written

Written

Purchased

Written

46,200

 71,700

 77,400

 104,700

 300

 31,200

 3,100

 44,000

 13,800

 8,200

270.00

270.00

270.00

270.00

240.00

240.00

270.00

230.00

240.00

230.00

American

American

American

American

American

American

American

American

American

American

17/12/2021

17/12/2021

17/12/2021

17/12/2021

15/10/2021

15/10/2021

17/12/2021

15/10/2021

16/07/2021

16/07/2021

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given.
Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the   Rules. If in doubt, consult the Panel.

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEPPUQUCUPGGCQ

a d v e r t i s e m e n t